FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2534979621> ?p ?o ?g. }

• W2534979621 endingPage "279" @default.
• W2534979621 startingPage "270" @default.
• W2534979621 abstract "Background: Anti-tumor necrosis factor (anti-TNF) monoclonal antibodies have revolutionized the treatment of inflammatory bowel diseases (IBD). However, because of their complexity, their production is expensive contributing to their high price. As the patent protection of these therapies has expired in several countries, biosimilars have been developed to reduce the healthcare costs. The aim of this article is to review the literature on the safety, efficacy and immunogenicity of biosimilars in IBD. </P><P> Methods: A PubMed literature search was performed using the following terms until May 2016: ‘biosimilars’, ‘CT-P13’, ‘infliximab’, ‘Crohn’s disease’, ‘ulcerative colitis’, ‘inflammatory bowel diseases’, ‘efficacy’, ‘safety’, ‘immunogenicity’. Additionally, abstracts from international meetings were also reviewed. </P><P> Results: A total of eleven studies in IBD patients provided real-world evidence on the efficacy, safety and immunogenicity profile of biosimilars in IBD patients. Based on the available evidence, CT-P13 is efficacious and well tolerated in IBD patients in a real-life setting. The vast majority of studies only included IBD patients who had never received biological therapies. Information regarding the interchangeability between CT-P13 and its originator is currently being investigated in the NOR-SWITCH trial. Otherwise, the immunogenicity profile of CT-P13 seems to be similar to the originator. </P><P> Conclusion: The infliximab biosimilar seems to be efficacious, safe and with a similar immunogenicity profile as the originator in IBD. Large prospective post-marketing studies are needed to assess the long-term safety profile of CT-P13. The use of infliximab biosimilars may lead to major healthcare cost savings." @default.
• W2534979621 created "2016-10-28" @default.
• W2534979621 creator A5032927697 @default.
• W2534979621 creator A5042884495 @default.
• W2534979621 date "2019-03-14" @default.
• W2534979621 modified "2023-10-18" @default.
• W2534979621 title "Efficacy, Safety and Immunogenicity of Biosimilars in Inflammatory Bowel Diseases: A Systematic Review" @default.
• W2534979621 cites W1827882046 @default.
• W2534979621 cites W1851453522 @default.
• W2534979621 cites W2025398922 @default.
• W2534979621 cites W2105792933 @default.
• W2534979621 cites W2108839201 @default.
• W2534979621 cites W2121050884 @default.
• W2534979621 cites W2130173462 @default.
• W2534979621 cites W2142933086 @default.
• W2534979621 cites W2148487286 @default.
• W2534979621 cites W2162768160 @default.
• W2534979621 cites W2208243538 @default.
• W2534979621 cites W2273714202 @default.
• W2534979621 cites W2308369648 @default.
• W2534979621 cites W2322840961 @default.
• W2534979621 cites W2342216265 @default.
• W2534979621 doi "https://doi.org/10.2174/0929867323666161014153346" @default.
• W2534979621 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27758715" @default.
• W2534979621 hasPublicationYear "2019" @default.
• W2534979621 type Work @default.
• W2534979621 sameAs 2534979621 @default.
• W2534979621 citedByCount "22" @default.
• W2534979621 countsByYear W25349796212016 @default.
• W2534979621 countsByYear W25349796212017 @default.
• W2534979621 countsByYear W25349796212018 @default.
• W2534979621 countsByYear W25349796212019 @default.
• W2534979621 countsByYear W25349796212020 @default.
• W2534979621 countsByYear W25349796212021 @default.
• W2534979621 countsByYear W25349796212022 @default.
• W2534979621 countsByYear W25349796212023 @default.
• W2534979621 crossrefType "journal-article" @default.
• W2534979621 hasAuthorship W2534979621A5032927697 @default.
• W2534979621 hasAuthorship W2534979621A5042884495 @default.
• W2534979621 hasConcept C126322002 @default.
• W2534979621 hasConcept C159654299 @default.
• W2534979621 hasConcept C177713679 @default.
• W2534979621 hasConcept C203014093 @default.
• W2534979621 hasConcept C2777138892 @default.
• W2534979621 hasConcept C2778260677 @default.
• W2534979621 hasConcept C2779134260 @default.
• W2534979621 hasConcept C2780479503 @default.
• W2534979621 hasConcept C2780868878 @default.
• W2534979621 hasConcept C535046627 @default.
• W2534979621 hasConcept C59491497 @default.
• W2534979621 hasConcept C71924100 @default.
• W2534979621 hasConceptScore W2534979621C126322002 @default.
• W2534979621 hasConceptScore W2534979621C159654299 @default.
• W2534979621 hasConceptScore W2534979621C177713679 @default.
• W2534979621 hasConceptScore W2534979621C203014093 @default.
• W2534979621 hasConceptScore W2534979621C2777138892 @default.
• W2534979621 hasConceptScore W2534979621C2778260677 @default.
• W2534979621 hasConceptScore W2534979621C2779134260 @default.
• W2534979621 hasConceptScore W2534979621C2780479503 @default.
• W2534979621 hasConceptScore W2534979621C2780868878 @default.
• W2534979621 hasConceptScore W2534979621C535046627 @default.
• W2534979621 hasConceptScore W2534979621C59491497 @default.
• W2534979621 hasConceptScore W2534979621C71924100 @default.
• W2534979621 hasIssue "2" @default.
• W2534979621 hasLocation W25349796211 @default.
• W2534979621 hasLocation W25349796212 @default.
• W2534979621 hasOpenAccess W2534979621 @default.
• W2534979621 hasPrimaryLocation W25349796211 @default.
• W2534979621 hasRelatedWork W2339588938 @default.
• W2534979621 hasRelatedWork W2541335332 @default.
• W2534979621 hasRelatedWork W2586965001 @default.
• W2534979621 hasRelatedWork W2587460980 @default.
• W2534979621 hasRelatedWork W2972178939 @default.
• W2534979621 hasRelatedWork W3003471368 @default.
• W2534979621 hasRelatedWork W3162050615 @default.
• W2534979621 hasRelatedWork W4234614328 @default.
• W2534979621 hasRelatedWork W4248260533 @default.
• W2534979621 hasRelatedWork W4282841296 @default.
• W2534979621 hasVolume "26" @default.
• W2534979621 isParatext "false" @default.
• W2534979621 isRetracted "false" @default.
• W2534979621 magId "2534979621" @default.
• W2534979621 workType "article" @default.